Crossmark

Development and validation of a disulfidptosis and M2 TAM-related classifier for bladder cancer to explore tumor subtypes, immune landscape and drug treatment

Crossref DOI link: https://doi.org/10.1007/s00432-023-05352-3

Published Online: 2023-09-05

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ren, Congzhe

Wang, Qihua

Xu, Zhunan

Pan, Yang

Li, Yuezheng

Liu, Xiaoqiang
License Information

Text and Data Mining valid from 2023-09-05

Version of Record valid from 2023-09-05
More Information

Article History

Received: 29 July 2023

Accepted: 25 August 2023

First Online: 5 September 2023

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below